{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:57:03Z","timestamp":1787497023000,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T00:00:00Z","timestamp":1647216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T00:00:00Z","timestamp":1647216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1208\/s12249-022-02232-w","type":"journal-article","created":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T21:02:45Z","timestamp":1647291765000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Transdermal Delivery of Baclofen Using Iontophoresis and Microneedles"],"prefix":"10.1208","volume":"23","author":[{"given":"Mohammad Shajid Ashraf","family":"Junaid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay K.","family":"Banga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,14]]},"reference":[{"key":"2232_CR1","first-page":"175","volume":"37","author":"MM Goldenberg","year":"2012","unstructured":"Goldenberg MM. Multiple sclerosis review. P and T. 2012;37:175\u201384.","journal-title":"P and T."},{"key":"2232_CR2","unstructured":"Mapping multiple sclerosis around the world key epidemiology findings Atlas of MS 3 rd edition. 2020 [cited 2021 Oct 31]; Available from: www.atlasofms.org"},{"key":"2232_CR3","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1177\/1352458519864681","volume":"26","author":"F Briggs","year":"2020","unstructured":"Briggs F, Hill E. Estimating the prevalence of multiple sclerosis using 56.6 million electronic health records from the United States. Mult Scler. 2020;26:1948\u201352.","journal-title":"Mult Scler"},{"key":"2232_CR4","first-page":"3","volume":"29","author":"H Gilmour","year":"2018","unstructured":"Gilmour H, Ramage-Morin PL, Wong SL. Multiple sclerosis: prevalence and impact. Health Reports. Statistics Canada. 2018;29:3\u20138.","journal-title":"Health Reports. Statistics Canada"},{"key":"2232_CR5","doi-asserted-by":"crossref","unstructured":"Clemens L, Langdon D. How does cognition relate to employment in multiple sclerosis? A systematic review. Multiple Sclerosis and Related Disorders. Elsevier; 2018;26:183\u2013191.","DOI":"10.1016\/j.msard.2018.09.018"},{"key":"2232_CR6","unstructured":"Ghanavatian S, Derian A. Baclofen [Internet]. The essence of analgesia and analgesics. StatPearls Publishing; 2021 [cited 2021 Nov 4]. p. 379\u201382. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK526037\/"},{"key":"2232_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1046\/j.1525-1403.2000.00075.x","volume":"3","author":"AM Avellino","year":"2000","unstructured":"Avellino AM, Loeser JD. Intrathecal baclofen for the treatment of intractable spasticity of spine or brain etiology. Neuromodulation: Technology at the Neural Interface. 2000;3:75\u201381.","journal-title":"Neuromodulation: Technology at the Neural Interface."},{"key":"2232_CR8","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1021\/acschemneuro.0c00254","volume":"11","author":"C Kent","year":"2020","unstructured":"Kent C, Park C, Lindsley C. Classics in chemical neuroscience: baclofen. ACS Chemical Neuroscience. 2020;11:1740\u201355.","journal-title":"ACS Chemical Neuroscience."},{"key":"2232_CR9","doi-asserted-by":"crossref","unstructured":"Agabio R, Sinclair JMA, Leggio L. The Cagliari Statement on baclofen for the treatment of alcohol use disorder: an International Consensus. French Journal of Psychiatry. 2019;1:S28.","DOI":"10.1016\/j.fjpsy.2019.10.216"},{"key":"2232_CR10","doi-asserted-by":"crossref","unstructured":"de Beaurepaire R, Sinclair JMA, Heydtmann M, Addolorato G, Aubin HJ, Beraha EM, et al. The use of baclofen as a treatment for alcohol use disorder: a clinical practice perspective. Frontiers in Psychiatry. Frontiers Media S.A.; 2019;10:708.","DOI":"10.3389\/fpsyt.2019.00338"},{"key":"2232_CR11","doi-asserted-by":"crossref","unstructured":"Agarwal SK, Kriel RL, Cloyd JC, Coles LD, Scherkenbach LA, Tobin MH, et al. A pilot study assessing pharmacokinetics and tolerability of oral and intravenous baclofen in healthy adult volunteers: Journal of Child Neurology. SAGE PublicationsSage CA: Los Angeles, CA; 2014;30:37\u201341.","DOI":"10.1177\/0883073814535504"},{"key":"2232_CR12","doi-asserted-by":"crossref","unstructured":"Schmitz NS, Krach LE, Coles LD, Mishra U, Agarwal SK, Cloyd JC, et al. A randomized dose escalation study of intravenous baclofen in healthy volunteers: clinical tolerance and pharmacokinetics. PM&R. No longer published by Elsevier; 2017;9:743\u2013750.","DOI":"10.1016\/j.pmrj.2016.11.002"},{"key":"2232_CR13","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1208\/pt0804100","volume":"8","author":"H Abdelkader","year":"2007","unstructured":"Abdelkader H, Abdalla OY, Salem H. Formulation of controlled-release baclofen matrix tablets: influence of some hydrophilic polymers on the release rate and in vitro evaluation. AAPS PharmSciTech. 2007;8:156\u201366.","journal-title":"AAPS PharmSciTech."},{"key":"2232_CR14","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2165\/00002018-200427110-00004","volume":"27","author":"A Dario","year":"2004","unstructured":"Dario A, Tomei G. A benefit-risk assessment of baclofen in severe spinal spasticity. Drug Safety. Springer. 2004;27:799\u2013818.","journal-title":"Drug Safety. Springer"},{"key":"2232_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6904-4-1","volume":"4","author":"I Mohammed","year":"2004","unstructured":"Mohammed I, Hussain A. Intrathecal baclofen withdrawal syndrome- a life-threatening complication of baclofen pump: a case report. BMC Clinical Pharmacology. BioMed Central. 2004;4:1\u20135.","journal-title":"BMC Clinical Pharmacology. BioMed Central"},{"key":"2232_CR16","unstructured":"Clinical Guidelines (Nursing) : Intrathecal baclofen therapy [Internet]. [cited 2021 Nov 5]. Available from: https:\/\/www.rch.org.au\/rchcpg\/hospital_clinical_guideline_index\/Intrathecal_baclofen_therapy\/#Complications"},{"key":"2232_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0378-5173(96)04514-0","volume":"137","author":"M Sznitowska","year":"1996","unstructured":"Sznitowska M, Janicki S, Gos T. The effect of sorption promoters on percutaneous permeation of a model zwitterion baclofen. International Journal of Pharmaceutics. 1996;137:125\u201332.","journal-title":"International Journal of Pharmaceutics."},{"key":"2232_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0378-5173(98)00360-3","volume":"179","author":"AK Banga","year":"1999","unstructured":"Banga AK, Bose S, Ghosh TK. Iontophoresis and electroporation: comparisons and contrasts. International Journal of Pharmaceutics. 1999;179:1\u201319.","journal-title":"International Journal of Pharmaceutics."},{"key":"2232_CR19","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1201\/b10906","volume-title":"Transdermal and intradermal delivery of therapeutic agents: application of physical technologies","author":"AK Banga","year":"2011","unstructured":"Banga AK. Transdermal and intradermal delivery of therapeutic agents: application of physical technologies. Boca Raton: CRC Press; 2011. p. 87\u201392."},{"key":"2232_CR20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0378-5173(00)00351-3","volume":"200","author":"SL Chang","year":"2000","unstructured":"Chang SL, Hofmann GA, Zhang L, Deftos LJ, Banga AK. Transdermal iontophoretic delivery of salmon calcitonin. Int J Pharm. 2000;200:107\u201313.","journal-title":"Int J Pharm."},{"key":"2232_CR21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ejps.2008.06.016","volume":"35","author":"S Bal","year":"2008","unstructured":"Bal S, Caussin J, Pavel S, Bouwstra J. In vivo assessment of safety of microneedle arrays in human skin. Eur J Pharm Sci. 2008;35:193\u2013202.","journal-title":"Eur J Pharm Sci."},{"key":"2232_CR22","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ejps.2013.05.005","volume":"50","author":"T Tuan-Mahmood","year":"2013","unstructured":"Tuan-Mahmood T, McCrudden M, Torrisi B, McAlister E, Garland M, Singh T, et al. Microneedles for intradermal and transdermal drug delivery. Eur J Pharm Sci. 2013;50:623\u201337.","journal-title":"Eur J Pharm Sci."},{"key":"2232_CR23","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1002\/jps.21981","volume":"99","author":"G Li","year":"2010","unstructured":"Li G, Badkar A, Kalluri H, Banga A. Microchannels created by sugar and metal microneedles: characterization by microscopy, macromolecular flux and other techniques. J Pharm Sci. 2010;99:1931\u201341.","journal-title":"J Pharm Sci"},{"key":"2232_CR24","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1023\/A:1016284815501","volume":"12","author":"NM Volpato","year":"1995","unstructured":"Volpato NM, Santi P, Colombo P. Iontophoresis enhances the transport of acyclovir through nude mouse skin by electrorepulsion and electroosmosis. Pharmaceutical Research. 1995;12:1623\u20137.","journal-title":"Pharmaceutical Research."},{"key":"2232_CR25","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s11095-021-03001-3","volume":"38","author":"K Saepang","year":"2021","unstructured":"Saepang K, Li SK, Chantasart D. Effect of pH on iontophoretic transport of pramipexole dihydrochloride across human epidermal membrane. Pharmaceutical Research. 2021;38:657\u201368.","journal-title":"Pharmaceutical Research."},{"key":"2232_CR26","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s13346-015-0241-3","volume":"5","author":"HX Nguyen","year":"2015","unstructured":"Nguyen HX, Banga AK. Enhanced skin delivery of vismodegib by microneedle treatment. Drug Delivery and Translational Research. 2015;5:407\u201323.","journal-title":"Drug Delivery and Translational Research."},{"key":"2232_CR27","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/nbt.1504","volume":"26","author":"MR Prausnitz","year":"2008","unstructured":"Prausnitz MR, Langer R. Transdermal drug delivery. Nature Biotechnology. 2008;26:1261\u20138.","journal-title":"Nature Biotechnology."},{"key":"2232_CR28","doi-asserted-by":"crossref","unstructured":"Garland MJ, Caffarel\u2013Salvador E, Migalska K, Woolfson AD, Donnelly RF. Dissolving polymeric microneedle arrays for electrically assisted transdermal drug delivery. Journal of Controlled Release : Official Journal of the Controlled Release Society. 2012;159:52, 59.","DOI":"10.1016\/j.jconrel.2012.01.003"},{"key":"2232_CR29","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s11095-010-0122-x","volume":"28","author":"H Kalluri","year":"2011","unstructured":"Kalluri H, Banga AK. Formation and closure of microchannels in skin following microporation. Pharmaceutical Research. 2011;28:82\u201394.","journal-title":"Pharmaceutical Research."},{"key":"2232_CR30","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ijpharm.2008.10.008","volume":"368","author":"G Li","year":"2009","unstructured":"Li G, Badkar A, Nema S, Kolli C, Banga A. In vitro transdermal delivery of therapeutic antibodies using maltose microneedles. Int J Pharm. 2009;368:109\u201315.","journal-title":"Int J Pharm."},{"key":"2232_CR31","doi-asserted-by":"publisher","first-page":"119853","DOI":"10.1016\/j.ijpharm.2020.119853","volume":"589","author":"M Kale","year":"2020","unstructured":"Kale M, Kipping T, Banga AK. Modulated delivery of donepezil using a combination of skin microporation and iontophoresis. Int J Pharm. 2020;589:119853.","journal-title":"Int J Pharm."},{"key":"2232_CR32","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s13346-017-0370-y","volume":"8","author":"Y Song","year":"2017","unstructured":"Song Y, Hemmady K, Puri A, Banga AK. Transdermal delivery of human growth hormone via laser-generated micropores. Drug Delivery and Translational Research. 2017;8:450\u201360.","journal-title":"Drug Delivery and Translational Research."}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-022-02232-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-022-02232-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-022-02232-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T14:04:55Z","timestamp":1647957895000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-022-02232-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,14]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["2232"],"URL":"https:\/\/doi.org\/10.1208\/s12249-022-02232-w","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,14]]},"assertion":[{"value":"24 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"84"}}